PepsiCo CEO Ramon Laguarta plans a bold reinvention of the company in 2026, part of a strategy for 2030. Focusing on innovation and competition from weight-loss drugs, PepsiCo aims to adapt to changing consumer needs.

Laguarta addresses the rising sales threat from weight-loss drugs and consumer affordability challenges. PepsiCo is leaning into portion control and functional hydration, offering smaller portions and more bespoke solutions to meet consumer demands.

PepsiCo shares rise after a strong fourth quarter, beating analyst estimates. The company reaffirms its outlook for 2026, promising cost cuts, lower prices, and new products like protein snacks. Investors await PepsiCo’s ability to deliver on its promises amidst skepticism.

Read more at Yahoo Finance: PepsiCo CEO reveals how he is tackling weight-loss drugs and consumer affordability challenges